A more than $100 million investment is fueling a new partnership designed to grow the healthcare workforce in Central Georgia ...
Federal health officials have proposed new rules that would require much faster decisions on prescription drug prior ...
The FDA has granted fast track designation to OPN-6602, an investigational oral dual inhibitor of EP300 and CREB-binding ...
Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results